KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to 0.41.

  • Exact Sciences' Equity Ratio rose 110.15% to 0.41 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.41, marking a year-over-year increase of 110.15%. This contributed to the annual value of 0.41 for FY2025, which is 110.15% up from last year.
  • Exact Sciences' Equity Ratio amounted to 0.41 in Q4 2025, which was up 110.15% from 0.42 recorded in Q3 2025.
  • Exact Sciences' 5-year Equity Ratio high stood at 0.54 for Q1 2021, and its period low was 0.41 during Q4 2024.
  • Moreover, its 5-year median value for Equity Ratio was 0.49 (2023), whereas its average is 0.48.
  • As far as peak fluctuations go, Exact Sciences' Equity Ratio surged by 1164.32% in 2021, and later crashed by 1662.6% in 2024.
  • Exact Sciences' Equity Ratio (Quarter) stood at 0.51 in 2021, then dropped by 3.56% to 0.49 in 2022, then decreased by 0.55% to 0.49 in 2023, then decreased by 16.63% to 0.41 in 2024, then rose by 1.1% to 0.41 in 2025.
  • Its Equity Ratio was 0.41 in Q4 2025, compared to 0.42 in Q3 2025 and 0.43 in Q2 2025.